Skip to content

Clinical trials

Phase 1/2 Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1/2 Country / region: Japan Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20122
20131
20141
20151
20161
20174
20194
20201
20211
20232
20241
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting12
Active, not recruiting8
Completed5
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
AbbVie2
AstraZeneca2
Daiichi Sankyo2
Eisai Inc.2
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
Tokyo University2
Ariad Pharmaceuticals1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms28
Carcinoma, Non-Small-Cell Lung6
Breast Neoplasms5
Endometrial Neoplasms5
Colonic Neoplasms4
Colorectal Neoplasms4
Head and Neck Neoplasms4
Lung Neoplasms4
Neoplasms by Histologic Type4
Neoplasms by Site4

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.